Technical Analysis for ABIO - ARCA biopharma, Inc.

Grade Last Price % Change Price Change
grade F 0.39 -5.20% -0.02
ABIO closed down 5.2 percent on Friday, March 22, 2019, on 34 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
12 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ABIO trend table...

Date Alert Name Type % Chg
Mar 22 Lower Bollinger Band Touch Weakness 0.00%
Mar 22 Oversold Stochastic Weakness 0.00%
Mar 21 Fell Below 50 DMA Bearish -5.20%
Mar 21 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -5.20%
Mar 21 Narrow Range Bar Range Contraction -5.20%
Mar 21 Earnings Movers Other -5.20%
Mar 21 Inside Day Range Contraction -5.20%
Mar 21 Oversold Stochastic Weakness -5.20%
Mar 20 Crossed Above 50 DMA Bullish -7.14%
Mar 20 Earnings Movers Other -7.14%

Older signals for ABIO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:

Profile
ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado.
Biopharmaceutical Cardiovascular Diseases Anatomy Heart Failure Atrial Fibrillation Cardiac Arrhythmia Heart Diseases Ventricular Dysfunction
Is ABIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Mar 18 Identification of Phosphodiesterease 3A Polymorphism With Potential to Increase Effectiveness of PDE3 Inhibitors Published in the Journal of the American College of Cardiology
Mar 6 Dose Response of Beta-Blockers in Adrenergic Receptor Polymorphism Genotypes Paper Published in Circulation: Genomic and Precision Medicine
Feb 27 ARCA biopharma reports Q4 results
Feb 27 ARCA biopharma Announces Fiscal Year 2018 Financial Results and Provides Corporate Update
Feb 20 Mid-Afternoon Market Update: Crude Oil Up 1.5%; Kandi Technologies Shares Spike Higher
Feb 20 54 Stocks Moving In Wednesday's Mid-Day Session
Feb 20 Mid-Day Market Update: LeMaitre Vascular Surges Following Strong Q4 Results; Sienna Biopharmaceuticals Shares Slide
Feb 20 ARCA Biopharma up 141% after FDA agreement for Phase 3 trial of Gencaro
Feb 20 ARCA Biopharma Announces FDA Agreement for a Single Phase 3 Clinical Trial to Support Approval for the First Genetically-Targeted Cardiovascular Drug
Jan 16 Zosano Appoints Linda Grais M.D., J.D. to Board of Directors
See more ABIO news...
Indicators
Indicator Value
52 Week High 1.28
52 Week Low 0.26
Average Volume 1,180,873
200-Day Moving Average 0.5331
50-Day Moving Average 0.4203
20-Day Moving Average 0.433
10-Day Moving Average 0.4101
Average True Range 0.0535
ADX 47.8
+DI 33.841
-DI 13.7074
Chandelier Exit (Long, 3 ATRs ) 0.4695
Chandelier Exit (Short, 3 ATRs ) 0.5305
Upper Bollinger Band 0.4871
Lower Bollinger Band 0.3789
Percent B (%b) 0.1
BandWidth 24.988453
MACD Line -0.0073
MACD Signal Line -0.0019
MACD Histogram -0.0054
Fundamentals Value
Market Cap 4.58 Million
Num Shares 11.7 Million
EPS -2.05
Price-to-Earnings (P/E) Ratio -0.19
Price-to-Sales 0.00
Price-to-Book 0.92
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.45
Resistance 3 (R3) 0.45 0.43 0.44
Resistance 2 (R2) 0.43 0.41 0.43 0.44
Resistance 1 (R1) 0.41 0.41 0.40 0.41 0.43
Pivot Point 0.39 0.39 0.38 0.39 0.39
Support 1 (S1) 0.37 0.37 0.36 0.37 0.35
Support 2 (S2) 0.35 0.37 0.35 0.34
Support 3 (S3) 0.33 0.35 0.34
Support 4 (S4) 0.33